Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancerGuangfa Bao, Xiaohua Zhu|European Journal of Nuclear Medicine and Molecular Imaging|2024Cited by 26